Novocardia

Novocardia is the dedicated value-based care division of CVAUSA. Following a merger of the two organizations, Novocardia now functions as the entity through which CVAUSA’s national network of cardiologists engages in risk-bearing contracts with payers. It supplies the care-model design, proprietary analytics, and contracting infrastructure while CVAUSA maintains the broader physician-network and practice-management relationship.

Across its network, Novocardia reports a 46% reduction in emergency room visits and a 43% reduction in cardiology-related hospital re-admissions compared to national averages. It also cites a 28% lower regional cost of care and appointment access up to four times faster than the national benchmark. These figures appear on the firm’s website and are attributed to its risk-stratification tools, same-day access protocols, and longitudinal heart failure management program.

Novocardia Care Solutions enters into multi-state value-based care agreements directly with insurers. In 2025, it announced a partnership with Humana covering eligible Medicare Advantage plan members. Under these arrangements, Novocardia assumes responsibility for managing cardiovascular cost and quality — targeting reductions in avoidable hospitalizations and ER visits — and both parties share performance data to drive ongoing care-quality improvements.

Novocardia partners with independent cardiology practices rather than employing physicians directly. It provides the analytics platform, clinical program design, and payer-contracting capabilities that allow those practices to participate in value-based reimbursement. The practices maintain clinical autonomy while Novocardia and CVAUSA supply the infrastructure needed for risk-bearing contracts.

Novocardia’s platform integrates electronic health record data and payer claims to feed risk-stratification models that track utilization, outcomes, and cost. It also deploys remote patient monitoring for vital signs and patient-reported outcomes, alongside purpose-built actuarial models intended to forecast cost dynamics. The firm describes these tools as proprietary, distinguishing its approach from practices that rely solely on standard EHR reporting.